Biological therapy was associated with significant changes in lung structure and, by extension, improved lung function in individuals with chronic obstructive pulmonary disease (COPD) and T2 ...

Small cell lung cancer (SCLC) may increase the risk of pneumonia due to a weakened immune system or structural changes to the lungs. SCLC is one of the two main types of lung cancer. Pneumonia is an ...

University of Delaware Assistant Professor Catherine Fromen and current graduate student Dominic Hoffman work with an adaptable lung model that can replicate realistic breathing maneuvers and offer ...

Background: Diagnosing acute exacerbation of chronic obstructive pulmonary disease (AECOPD) remains challenging in clinical practice. Computed tomography (CT) plays a great role in characterizing and ...

Branching patterns are prevalent in our natural environment and the human body, such as in the lungs and kidneys. For example, specific genes that express growth factor proteins are known to influence ...

Emphysematous changes refer to changes that may occur in the lungs as emphysema progresses and are visible on a CT scan. This may include changes in location or the type of damage in the lungs due to ...

Brensocatib, a DPP1 inhibitor, is the first FDA-approved therapy for non-cystic fibrosis bronchiectasis, showing significant clinical and structural benefits. The ASPEN trial demonstrated that ...

Lung metastases are a devastating reality for over half of cancer patients whose tumors spread beyond their initial sites. These secondary lung tumors develop in part because of unique conditions ...

Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depends on the ability to deliver tiny particles known as aerosols to the correct location in ...